Sachdev Amit

EVP Chief Patient &Ext Af Off | EVP, Chief Patient Officer | EVP, CRO

1 company

Weak

Trades Analyzed

12M Win Rate

7.7%

Avg 3M Return

-4.3%

Avg 12M Return

-19.7%

Sachdev Amit is an EVP Chief Patient &Ext Af Off at VERTEX PHARMACEUTICALS INC / MA. Recent SEC Form 4 filings include 0 buys and 61 sells.

Estimated insider holdings value: $31.0M based on current market prices.

Holdings by Company

VRTXFeb 26, 2025

Current Shares68.5K

Value$31.03M

Net Activity-176,983

Bought: 0Sold: 177.0K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 25, 2021	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	3,586	$213.42	$765,307.40	-1.7%	-2.9%	+8.1%
Feb 18, 2021	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	9,264	$211.83	$1,962,366.00	-4.4%	+2.0%	+9.4%
Feb 11, 2021	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	4,460	$210.55	$939,067.80	-2.3%	+1.0%	+11.1%
Nov 16, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	42	$223.53	$9,388.24	-	-	-
Aug 3, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sale+OE	1,941	$278.28	$540,136.68	-1.8%	-	-
May 15, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	58	$284.41	$16,495.71	-	-	-
May 11, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sale+OE	9,953	$281.96	$2,806,318.36	-2.4%	-	-
May 6, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sale+OE	669	$275.28	$184,162.32	-1.9%	-	-
May 5, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sale+OE	57,108	$264.09	$15,081,411.55	-7.7%	-	-
Feb 25, 2020	VRTX Vertex Pharmaceuticals Inc / Ma	EVP, Chief Patient Officer	Sell	3,376	$233.53	$788,401.88	-1.2%	-	-